Regardless of the types of rHuEPO, CKD patients with HLA-B*46:01:01:01 or HLA-DRB1*09:01:02:01 had a three to sixfold increased risk of developing anti-rHuEPO-induced PRCA. This evidence concerns the gene HLA-B and pure red-cell aplasia.